A Retrospective Hospital-Based Study of HMGCR Expression in HER2 IHC 2+ and 3+ Breast Cancer

OBJECTIVE: The role of HMG-CoA reductase (HMGCR) in relation to prognostic and treatment predictive information of HER2 positive breast cancer has been newly explored. In this study, we aimed to determine the expression of HMGCR in HER2 immunohistochemistry (IHC) scores of 2+ and 3+ breast cancer an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Malisalaora, Mohd Nafi, Siti Norasikin, Jaafar, Hasnan, Paiman, Noorasmaliza Md
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607074/
https://www.ncbi.nlm.nih.gov/pubmed/34319025
http://dx.doi.org/10.31557/APJCP.2021.22.7.2043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607074/
https://www.ncbi.nlm.nih.gov/pubmed/34319025
http://dx.doi.org/10.31557/APJCP.2021.22.7.2043

Ejemplares similares